文献速递糖尿病肥胖与代谢综合征骨质疏松与钙磷/甲状旁腺

成纤维细胞生长因子23、血糖稳态与新发糖尿病:两项队列研究结果

Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

研究纳入45名超重个体分析葡萄糖负荷对FGF23的影响,并在5482人队列中分析FGF23与血糖稳态及新发糖尿病、肥胖的关联。葡萄糖负荷后FGF23变化先于血磷变化;FGF23与血糖、胰岛素、胰岛素原相关,并与新发糖尿病(HR 1.66)和肥胖(HR 1.84)独立相关,但校正BMI后糖尿病关联失去显著性。

要点

  • 葡萄糖负荷后FGF23变化先于血磷变化(时间滞后分析P=0.04)。
  • FGF23与基线血糖、胰岛素、胰岛素原正相关。
  • FGF23与新发糖尿病和肥胖相关,但糖尿病关联在校正BMI后不再显著。

核心结论

  • 葡萄糖负荷对FGF23有独立于磷的影响,反之FGF23与血糖、胰岛素、胰岛素原及肥胖相关,提示FGF23与血糖稳态存在交互作用,可能促进新发糖尿病易感性。

研究设计与样本

  • 第一项分析在45名超重(BMI 25-30)个体中采用时间滞后分析研究葡萄糖负荷对血浆C端FGF23及血磷变化的影响。
  • 第二项为基于人群的队列研究(N=5482;平均年龄52岁,52%女性,FGF23中位数69 RU/mL),采用多变量线性回归分析横断面关联,多变量Cox回归分析新发糖尿病和肥胖,并探索BMI的效应修饰。

主要发现

  • 葡萄糖负荷后FGF23变化先于血浆磷酸盐变化(P时间滞后=0.04)。
  • 基线时FGF23与血糖(β=0.13 [0.03-0.23];P=0.01)、胰岛素(β=0.10 [0.03-0.17];P<0.001)和胰岛素原(β=0.06 [0.02-0.10];P=0.01)相关。
  • 纵向分析中,较高的基线FGF23独立关联新发糖尿病(199例事件[4%];完全校正HR 1.66 [95%CI 1.06-2.60];P=0.03)和新发肥胖(241例事件[6%];完全校正HR 1.84 [95%CI 1.34-2.50];P<0.001)。
  • 额外校正BMI后,FGF23与新发糖尿病的关联失去显著性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The phosphate-regulating hormone fibroblast growth factor 23 (FGF23) has been linked to deregulations in glucose metabolism, but its role is insufficiently understood. OBJECTIVE: This study investigates potential crosstalk between FGF23 and glucose homeostasis. METHODS: First, we investigated the effect of glucose loading on plasma C-terminal FGF23 levels and its temporal relationship with changes in plasma phosphate in 45 overweight (body mass index [BMI] 25-30) individuals using time-lag analyses. Second, we studied cross-sectional associations of plasma C-terminal FGF23 levels with glucose homeostasis using multivariable linear regression in a population-based cohort. We also investigated associations of FGF23 with incident diabetes and obesity (BMI > 30) in individuals without diabetes or obesity at baseline, respectively, using multivariable Cox regression analyses. Finally, we explored whether the association between FGF23 and diabetes depends on BMI. RESULTS: After glucose loading, changes in FGF23 preceded changes in plasma phosphate (Ptime-lag = .04). In the population-based cohort (N = 5482; mean age 52 years, 52% women, median FGF23 69 RU/mL), FGF23 was associated with plasma glucose (β = .13 [.03-.23]; P = .01), insulin (β = .10 [.03-.17]; P < .001), and proinsulin (β = .06 [0.02-0.10]; P = .01) at baseline. On longitudinal analyses, a higher baseline FGF23 was independently associated with development of diabetes (199 events [4%]; fully adjusted hazard ratio [HR] 1.66 [95% CI, 1.06-2.60]; P = .03) and development of obesity (241 events [6%]; fully adjusted HR 1.84 [95% CI, 1.34-2.50]; P < .001). The association between FGF23 and incident diabetes lost significance after additional adjustment for BMI. CONCLUSION: Glucose loading has phosphate-independent effects on FGF23 and, vice versa, FGF23 is associated with glucose, insulin and proinsulin levels, and obesity. These findings suggest crosstalk between FGF23 and glucose homeostasis, which may promote susceptibility to incident diabetes.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. van der Vaart A, Eelderink C, van Beek AP, et al. Fibroblast Growth Factor 23, Glucose Homeostasis, and Incident Diabetes: Findings of 2 Cohort Studies. J Clin Endocrinol Metab. 2023. PMID: 37139691. doi:10.1210/clinem/dgad246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。